The University of Tennessee Health Science Center and St. Jude Children’s Research Hospital will receive grants from the U.S. Department of Health and Human Services, announced Congressman Steve Cohen. UTHSC will receive $635,969 for research on endothelial cells from the National Heart, Blood and Lung Institute and $500,000 for research on sexual assault examiners from… Read More
Scientists at St. Jude Children’s Research Hospital have identified genetic variants in African American childhood cancer survivors that have implications for up-front care and long-term surveillance. December 8: Mirage News
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center (UTHSC) now offer a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study known as ENSEMBLE. This large clinical trial involving up to 60,000 volunteers evaluates the safety and efficacy of the Janssen investigational COVID-19… Read More
The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children’s Research Hospital scientists have discovered a potential strategy to prevent life-threatening inflammation, lung damage and organ failure in patients with COVID-19. The research appeared online in the journal Cell. November 19: KSDK NewsChannel 5 November 19:… Read More
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are recruiting adult participants for a phase 3 COVID-19 vaccine clinical trial. More information about the trial, including participant eligibility requirements, is available here. The two are partnering to offer a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s… Read More
Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ENSEMBLE trial.
Congressman Steve Cohen (TN-09) today announced that St. Jude Children’s Research Center and the University of Tennessee Health Science Center (UTHSC) will each be receiving a National Institutes of Health (NIH) grant to continue their critical research.
The St. Baldrick’s Foundation has awarded a $175,612 fellowship grant to St. Jude Children’s Research Hospital and a $5,000 Summer Fellowship grant to the University of Tennessee Health Science Center (UTHSC). St. Baldrick’s is a not-for-profit organization based in Monrovia, California, and the nation’s largest private funder of childhood cancer research grants.
